New findings about key pathological protein in Parkinson's disease open paths to novel therapies
byJohns Hopkins University School of MedicineSecond row shows how rapamycin dampens alpha-synuclein protein production in a magnified area of a mouse brain. Credit: Mohammed Khan and Ted Dawson,
Updated on: December 30,2023
5

New findings about key pathological protein in Parkinson's disease open paths to novel therapies
byJohns Hopkins University School of MedicineSecond row shows how rapamycin dampens alpha-synuclein protein production in a magnified area of a mouse brain. Credit: Mohammed Khan and Ted Dawson,
Updated on:December 30,2023
5
